These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

765 related items for PubMed ID: 26945548

  • 1. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.
    Holder RM, Rhee D.
    Pharmacotherapy; 2016 Mar; 36(3):287-99. PubMed ID: 26945548
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation.
    White WB, Kowey P, Diva U, Sostek M, Tummala R.
    J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):309-317. PubMed ID: 29504415
    [Abstract] [Full Text] [Related]

  • 3. Naloxegol: a review of its use in patients with opioid-induced constipation.
    Garnock-Jones KP.
    Drugs; 2015 Mar; 75(4):419-25. PubMed ID: 25666542
    [Abstract] [Full Text] [Related]

  • 4. Naloxegol for managing opioid-induced constipation.
    Shelton KN, Clements JN.
    JAAPA; 2017 Sep; 30(9):51-53. PubMed ID: 28858018
    [Abstract] [Full Text] [Related]

  • 5. Naloxegol: the first orally administered, peripherally acting, mu opioid receptor antagonist, approved for the treatment of opioid-induced constipation.
    Corsetti M, Tack J.
    Drugs Today (Barc); 2015 Aug; 51(8):479-89. PubMed ID: 26380386
    [Abstract] [Full Text] [Related]

  • 6. Naloxegol for opioid-induced constipation in patients with noncancer pain.
    Chey WD, Webster L, Sostek M, Lappalainen J, Barker PN, Tack J.
    N Engl J Med; 2014 Jun 19; 370(25):2387-96. PubMed ID: 24896818
    [Abstract] [Full Text] [Related]

  • 7. Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation.
    Jones R, Prommer E, Backstedt D.
    Am J Hosp Palliat Care; 2016 Nov 19; 33(9):875-880. PubMed ID: 26150678
    [Abstract] [Full Text] [Related]

  • 8. Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation.
    Webster L, Chey WD, Tack J, Lappalainen J, Diva U, Sostek M.
    Aliment Pharmacol Ther; 2014 Oct 19; 40(7):771-9. PubMed ID: 25112584
    [Abstract] [Full Text] [Related]

  • 9. Opioid-induced constipation in chronic noncancer pain.
    Weber HC.
    Curr Opin Endocrinol Diabetes Obes; 2016 Feb 19; 23(1):11-7. PubMed ID: 26702846
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK.
    Lawson R, Ryan J, King F, Goh JW, Tichy E, Marsh K.
    Pharmacoeconomics; 2017 Feb 19; 35(2):225-235. PubMed ID: 27663572
    [Abstract] [Full Text] [Related]

  • 14. A 12-week extension study to assess the safety and tolerability of naloxegol in patients with noncancer pain and opioid-induced constipation.
    Webster L, Tummala R, Diva U, Lappalainen J.
    J Opioid Manag; 2016 Feb 19; 12(6):405-419. PubMed ID: 28059433
    [Abstract] [Full Text] [Related]

  • 15. The impact of naloxegol on anal sphincter function - Using a human experimental model of opioid-induced bowel dysfunction.
    Grønlund D, Poulsen JL, Krogh K, Brock C, Liao D, Gregersen H, Drewes AM, Olesen AE.
    Eur J Pharm Sci; 2018 May 30; 117():187-192. PubMed ID: 29432808
    [Abstract] [Full Text] [Related]

  • 16. Insights on efficacious doses of PAMORAs for patients on chronic opioid therapy or opioid-naïve patients.
    van Malderen K, Halawi H, Camilleri M.
    Neurogastroenterol Motil; 2018 May 30; 30(5):e13250. PubMed ID: 29119706
    [Abstract] [Full Text] [Related]

  • 17. Naloxegol: A Review of Clinical Trials and Applications to Practice.
    Dume R, Shuman M.
    Orthop Nurs; 2019 May 30; 38(3):209-211. PubMed ID: 31124873
    [Abstract] [Full Text] [Related]

  • 18. Evaluating naloxegol for the treatment of opioid-induced constipation.
    Daniali M, Nikfar S, Abdollahi M.
    Expert Opin Pharmacother; 2020 Jun 30; 21(8):883-891. PubMed ID: 32129103
    [Abstract] [Full Text] [Related]

  • 19. Treating Opioid-Induced Constipation in Older Adults: New Options.
    Sani H, Mahan RJ.
    Consult Pharm; 2015 Oct 30; 30(10):612-5. PubMed ID: 26450143
    [Abstract] [Full Text] [Related]

  • 20. Systematic review with meta-analysis: efficacy and safety of treatments for opioid-induced constipation.
    Vijayvargiya P, Camilleri M, Vijayvargiya P, Erwin P, Murad MH.
    Aliment Pharmacol Ther; 2020 Jul 30; 52(1):37-53. PubMed ID: 32462777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.